Michael J. Sofia is Chief Scientific Officer of Arbutus Biopharma Corp. Currently has a direct ownership of 1.49 Million shares of ABUS, which is worth approximately $5.21 Million. The most recent transaction as insider was on Feb 02, 2024, when has been sold 9,982 shares (Common Shares) at a price of $2.31 per share, resulting in proceeds of $23,058. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.49M
0% 3M change
7.18% 12M change
Total Value Held $5.21 Million

Michael J. Sofia Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 02 2024
SELL
Open market or private sale
$23,058 $2.31 p/Share
9,982 Reduced 0.67%
1,485,121 Common Shares
Feb 01 2024
BUY
Grant, award, or other acquisition
-
109,500 Added 6.82%
1,495,103 Common Shares
Feb 01 2023
BUY
Grant, award, or other acquisition
-
82,200 Added 5.6%
1,385,603 Common Shares
Dec 01 2021
SELL
Open market or private sale
$1,018,000 $5.09 p/Share
200,000 Reduced 13.3%
1,303,403 Common Shares
MJS

Michael J. Sofia

Chief Scientific Officer
Warminster, PA

Track Institutional and Insider Activities on ABUS

Follow Arbutus Biopharma Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ABUS shares.

Notify only if

Insider Trading

Get notified when an Arbutus Biopharma Corp insider buys or sells ABUS shares.

Notify only if

News

Receive news related to Arbutus Biopharma Corp

Track Activities on ABUS